Intrapleural Chemotherapy
Hyperthermia combined with intra-thoracic chemotherapy and radiotherapy for malignant pleural mesothelioma
Annals of Surgerical Oncology. 2006 Nov 1; [Epub ahead of print] [Link] Xia H, Karasawa K, Hanyu N, Chang TC, Okamoto M, Kiguchi Y, Kawakami M, Itazawa T. Department of Radiation Oncology, Tokyo Metropolitan Komagome Hospital, Tokyo, Japan. Abstract Background: Prognosis for patients with malignant pleural mesothelioma (MPM) remains poor and such patients require intensive…
Read MoreFatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma
International Journal of Radiation Oncology, Biology, Physics. 2006 Jul 1;65(3):640-645. [Link] Allen AM, Czerminska M, Janne PA, Sugarbaker DJ, Bueno R, Harris JR, Court L, Baldini EH. Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women’s Hospital, Boston, MA. Abstract Purpose: To describe the initial experience at Dana-Farber Cancer Institute/Brigham and Women’s Hospital…
Read More“Therapeutic” pleural surgery
Revue de Pneumologique Clinique. 2006 Apr;62(2):142-7. [Link] Venissac N, Mouroux J. Service de Chirurgie Thoracique, Hopital Pasteur, CHU de Nice, 30, avenue de la Voie-Romaine, 06000 Nice. venisac.n@chu-nice.fr Abstract Renewed interest in carcinological pleura surgery for the treatment of mesothelioma has resulted from an increased incidence of the tumor and also better control of postoperative…
Read MorePhase I to II Study of Pleurectomy/Decortication and Intraoperative Intracavitary Hyperthermic Cisplatin Lavage for Mesothelioma
Journal of Clinical Oncology, Vol 24, No 10 (April 1), 2006: pp. 1561-1567 [Link] William G. Richards, Lambros Zellos, Raphael Bueno, Michael T. Jaklitsch, Pasi A. Jänne, Lucian R. Chirieac, Beow Y. Yeap, Rene J. Dekkers, Phillip M. Hartigan, Leah Capalbo, David J. Sugarbaker From the Brigham and Women’s Hospital; Dana-Farber Cancer Institute; and Massachusetts…
Read MoreIntrapleural topical application of cisplatin with the surgical carrier Vivostat increases the local drug concentration in an immune-competent rat model with malignant pleuromesothelioma
The Journal of Thoracic and Cardiovascular Surgery. 2006 Mar;131(3):697-703.e3. Received 2 June 2005; revised 5 August 2005; accepted 17 August 2005. Available online 2 March 2006. [Link] D. Lardinois MDa, F.J. Jung MDa, I. Opitz MDa, K. Rentsch MDb, C. Latkoczy MDc, V. Vuong PhDd, Z. Varga MDe, V. Rousson PhDf, D. Günther MDc, S.…
Read MorePatterns of failure following surgical resection for malignant pleural mesothelioma
Thoracic Surgery Clinics. 2004 Nov;14(4):567-73. [Link] Janne PA, Baldini EH Harvard Medical School, Boston, MA 02115, USA. pjanne@partners.org Abstract The optimum therapeutic strategy for patients with localized malignant mesothelioma continues to evolve. For patients who are eligible candidates, surgical resection plays an important role. An encouraging 45% 5-year survival rate has been reported for patients…
Read More